Skip to content
PubMed This is a summary of 50 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 50 referenced papers

Top Authors

Lisa A. Maier
National Jewish Health
Margaret M. Mroz
National Jewish Health
Andrew P. Fontenot
University of Colorado Anschutz Medical Campus
Björn C. Frye
University Medical Center Freiburg
Vincent Cottin
Université Claude Bernard Lyon 1
Tasha E. Fingerlin
National Jewish Health
Douglas G. Mack
University of Colorado Anschutz Medical Campus
Shaikh M. Atif
University of Colorado Anschutz Medical Campus
Gernot Zissel
University Medical Center Freiburg
Kenneth D. Rosenman
Michigan State University

Top Institutions

Ranked by publications Top 10 institutions
05

University Medical Center Freiburg

Freiburg im Breisgau, Germany

7 papers
10

National Institute for Occupational Safety and Health

Washington, United States

5 papers

References

References (50)
  1. 1

    Metal-specific CD4+ T-cell responses induced by beryllium exposure in HLA-DP2 transgenic mice.

    Falta MT, Tinega AN, Mack DG, et al.

    Mucosal immunology 2016; (9(1)):218-28 doi:10.1038/mi.2015.54.

    PMID: 26129650
  2. 2

    Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.

    Fontenot AP, Falta MT, Kappler JW, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2016; (196(1)):22-7 doi:10.4049/jimmunol.1502011.

    PMID: 26685315
  3. 3

    Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

    Collard HR, Ryerson CJ, Corte TJ, et al.

    American journal of respiratory and critical care medicine 2016; (194(3)):265-75 doi:10.1164/rccm.201604-0801CI.

    PMID: 27299520
  4. 4

    A mortality study of beryllium workers.

    Boffetta P, Fordyce TA, Mandel JS

    Cancer medicine 2016; (5(12)):3596-3605 doi:10.1002/cam4.918.

    PMID: 27766788
  5. 5

    Occupational Exposure to Beryllium. Final rule.

    Federal register 2017; (82(5)):2470-757.

    PMID: 28071878
  6. 6

    Differential diagnosis of granulomatous lung disease: clues and pitfalls: Number 4 in the Series "Pathology for the clinician" Edited by Peter Dorfmüller and Alberto Cavazza.

    Ohshimo S, Guzman J, Costabel U, Bonella F

    European respiratory review : an official journal of the European Respiratory Society 2017; (26(145)) doi:10.1183/16000617.0012-2017.

    PMID: 28794143
  7. 7

    [Differential Diagnosis of Mediastinal and Hilar Lymphadenopathy with Focus on Occupational Diseases].

    Lux H, Cavalcante LB, Baur X

    Pneumologie (Stuttgart, Germany) 2018; (72(6)):423-436 doi:10.1055/s-0043-119647.

    PMID: 29046010
  8. 8

    5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.

    Day BJ, Huang J, Barkes BQ, et al.

    Lung 2018; (196(1)):103-114 doi:10.1007/s00408-017-0062-x.

    PMID: 29080069
  9. 9

    Predictors of Intubation in Patients With Acute Hypoxemic Respiratory Failure Treated With a Noninvasive Oxygenation Strategy.

    Frat JP, Ragot S, Coudroy R, et al.

    Critical care medicine 2018; (46(2)):208-215 doi:10.1097/CCM.0000000000002818.

    PMID: 29099420
  10. 10

    Clinical tool for disease phenotyping in granulomatous lung disease.

    Silveira LJ, Strand M, Van Dyke MV, et al.

    PloS one 2017; (12(11)):e0188119 doi:10.1371/journal.pone.0188119.

    PMID: 29145499
  11. 11

    Effect of inhaled corticosteroids on lung function in chronic beryllium disease.

    Mroz MM, Ferguson JH, Faino AV, et al.

    Respiratory medicine 2018; (138S()):S14-S19 doi:10.1016/j.rmed.2018.01.009.

    PMID: 29453139
  12. 12

    Clinical and laboratory factors contributing to uninterpretable beryllium lymphocyte proliferation tests (BeLPT).

    Smith DE, Golden AP, Stange AW, et al.

    American journal of industrial medicine 2018; (61(7)):592-604 doi:10.1002/ajim.22842.

    PMID: 29574954
  13. 13

    Immunologic Effects of Beryllium Exposure.

    Fontenot AP

    Annals of the American Thoracic Society 2018; (15(Suppl 2)):S81-S85 doi:10.1513/AnnalsATS.201707-573MG.

    PMID: 29676647
  14. 14

    Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights.

    Faverio P, De Giacomi F, Sardella L, et al.

    BMC pulmonary medicine 2018; (18(1)):70 doi:10.1186/s12890-018-0643-3.

    PMID: 29764401
  15. 15

    Polymorphism of FCGR3A gene in chronic beryllium disease.

    Liu B, Maier LA, Hamzeh N, et al.

    Genes and immunity 2019; (20(6)):493-499 doi:10.1038/s41435-018-0046-8.

    PMID: 30245507
  16. 16

    Translational research in pulmonary fibrosis.

    Mathai SK, Schwartz DA

    Translational research : the journal of laboratory and clinical medicine 2019; (209()):1-13 doi:10.1016/j.trsl.2019.02.001.

    PMID: 30768925
  17. 17

    Granulomatous lung disease in two workers making light bulbs.

    Ronsmans S, Verbeken EK, Adams E, et al.

    American journal of industrial medicine 2019; (62(10)):908-913 doi:10.1002/ajim.23030.

    PMID: 31347732
  18. 18

    Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.

    Virji MA, Schuler CR, Cox-Ganser J, et al.

    Annals of work exposures and health 2019; (63(8)):856-869 doi:10.1093/annweh/wxz064.

    PMID: 31504146
  19. 19

    A role for TNF-α in alveolar macrophage damage-associated molecular pattern release.

    Collins MK, Shotland AM, Wade MF, et al.

    JCI insight 2020; (5(9)).

    PMID: 32255768
  20. 20

    Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.

    Greaves SA, Atif SM, Fontenot AP

    Frontiers in immunology 2020; (11()):474 doi:10.3389/fimmu.2020.00474.

    PMID: 32256501
  21. 21

    [Diagnostic difficulties of chronic pulmonary berylliosis in France].

    Ghanem M, Naccache JM, Bonneterre V, et al.

    Revue des maladies respiratoires 2020; (37(5)):364-368 doi:10.1016/j.rmr.2020.03.003.

    PMID: 32279890
  22. 22

    Chronic Beryllium Disease: Update on a Moving Target.

    MacMurdo MG, Mroz MM, Culver DA, et al.

    Chest 2020; (158(6)):2458-2466 doi:10.1016/j.chest.2020.07.074.

    PMID: 32768458
  23. 23

    A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.

    Frye BC, Quartucci C, Rakete S, et al.

    Chest 2021; (159(3)):1084-1093 doi:10.1016/j.chest.2020.09.073.

    PMID: 32926872
  24. 24

    Pneumoconiosis with a Sarcoid-Like Reaction Other than Beryllium Exposure: A Case Report and Literature Review.

    Hayashi F, Kido T, Sakamoto N, et al.

    Medicina (Kaunas, Lithuania) 2020; (56(11)) doi:10.3390/medicina56110630.

    PMID: 33266389
  25. 25

    Pathology of Granulomatous Pulmonary Diseases.

    Rosen Y

    Archives of pathology & laboratory medicine 2022; (146(2)):233-251 doi:10.5858/arpa.2020-0543-RA.

    PMID: 33905479
  26. 26

    HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.

    Crooks J, Mroz MM, VanDyke M, et al.

    Occupational and environmental medicine 2022; (79(2)):120-126 doi:10.1136/oemed-2021-107736.

    PMID: 34535537
  27. 27

    [Sarcoidosis and berylliosis].

    Soriano D, Quartucci C, Agarwal P, et al.

    Der Internist 2022; (63(5)):557-565 doi:10.1007/s00108-022-01323-x.

    PMID: 35397695
  28. 28

    Assessment of dermal absorption of beryllium and copper contained in temple tips of eyeglasses.

    Magnano GC, Marussi G, Adami G, et al.

    Toxicology letters 2022; (361()):64-71 doi:10.1016/j.toxlet.2022.04.001.

    PMID: 35427767
  29. 29

    Mechanical Ventilation for COVID-19 Patients.

    Brioni M, Meli A, Grasselli G

    Seminars in respiratory and critical care medicine 2022; (43(3)):405-416 doi:10.1055/s-0042-1744305.

    PMID: 35439831
  30. 30

    Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease.

    Atif SM, Mack DG, Martin AK, Fontenot AP

    JCI insight 2022; (7(16)).

    PMID: 35819849
  31. 31

    Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.

    Cloeren M, Dement J, Gaitens J, et al.

    American journal of industrial medicine 2022; (65(9)):708-720 doi:10.1002/ajim.23411.

    PMID: 35833586
  32. 32

    Elemental analysis of contemporary dental materials regarding potential beryllium content.

    Burkhardt F, Pieralli S, Bergfeldt T, et al.

    Scientific reports 2022; (12(1)):19119 doi:10.1038/s41598-022-21068-9.

    PMID: 36351929
  33. 33

    Interstitial Lung Disease: A Focused Review for the Emergency Clinician.

    Constantino K, Gottlieb M, Long B

    The Journal of emergency medicine 2023; (64(2)):156-166 doi:10.1016/j.jemermed.2022.10.015.

    PMID: 36707347
  34. 34

    Differential diagnosis of pulmonary sarcoidosis: a review.

    Valeyre D, Brauner M, Bernaudin JF, et al.

    Frontiers in medicine 2023; (10()):1150751 doi:10.3389/fmed.2023.1150751.

    PMID: 37250639
  35. 35

    Para-occupational exposure to chemical substances: a systematic review.

    Ramezanifar S, Azimian A, Khadiv E, et al.

    Reviews on environmental health 2024; (39(4)):737-754 doi:10.1515/reveh-2023-0019.

    PMID: 37525484
  36. 36

    Occupational interstitial lung diseases.

    Spagnolo P, Ryerson CJ, Guler S, et al.

    Journal of internal medicine 2023; (294(6)):798-815 doi:10.1111/joim.13707.

    PMID: 37535448
  37. 37

    Mortality Among Individuals Diagnosed With Chronic Beryllium Disease and Beryllium Sensitization.

    TenHarmsel H, Wang L, Dumas C, Rosenman KD

    Journal of occupational and environmental medicine 2024; (66(3)):247-251 doi:10.1097/JOM.0000000000003033.

    PMID: 38151991
  38. 38

    Mortality of older construction and craft workers employed at Department of Energy (DOE) nuclear sites: Follow-up through 2021.

    Ringen K, Dement J, Cloeren M, et al.

    American journal of industrial medicine 2024; (67(3)):261-273 doi:10.1002/ajim.23567.

    PMID: 38273456
  39. 39

    Granulomatous Lung Diseases: A Practical Approach and Review of Common Entities.

    Chan JCK, Boland JM

    Surgical pathology clinics 2024; (17(2)):173-192 doi:10.1016/j.path.2023.11.004.

    PMID: 38692803
  40. 40

    Multisystemic Beryllium Disease: An Exceptional Case Revealed by a Urinary Tract Granulomatosis.

    Jacobs L, Taghavi M, Fallas J, et al.

    International journal of molecular sciences 2024; (25(15)) doi:10.3390/ijms25158166.

    PMID: 39125734
  41. 41

    Oxygen therapy and noninvasive respiratory supports in acute hypoxemic respiratory failure: a narrative review.

    Thille AW, Balen F, Carteaux G, et al.

    Annals of intensive care 2024; (14(1)):158 doi:10.1186/s13613-024-01389-w.

    PMID: 39419924
  42. 42

    Sarcoidosis in Beryllium Exposed Workers: A Case-Case Study.

    Mayer AS, Mroz MM, Van Dyke MK, et al.

    American journal of industrial medicine 2025; (68(1)):68-75 doi:10.1002/ajim.23676.

    PMID: 39584481
  43. 43

    The Management of Interstitial Lung Disease in the ICU: A Comprehensive Review.

    Dhanani Z, Gupta R

    Journal of clinical medicine 2024; (13(22)) doi:10.3390/jcm13226657.

    PMID: 39597801
  44. 44

    Beryllium Lymphocyte Proliferation Test: Differential Diagnosis of Sarcoidosis and Chronic Beryllium Disease.

    Jouanjan L, Terschluse C, Zissel G, et al.

    Chest 2025; (168(6)):1404-1414 doi:10.1016/j.chest.2025.06.034.

    PMID: 40609857
  45. 45

    Mindfulness-Based Interventions for Chronic Pulmonary Diseases: A Systematic Review of Effects on Anxiety, Depression, Stress, Dyspnea, and Quality of Life.

    Bramanti A, Pessolano C, Garofano M, et al.

    Bioengineering (Basel, Switzerland) 2025; (12(9)) doi:10.3390/bioengineering12090931.

    PMID: 41007176
  46. 46

    Genome-wide association study and HLA genotyping for beryllium disease susceptibility in a European descent population.

    Liao SY, Fingerlin TE, Jacobson S, et al.

    Gene 2025; (971()):149820 doi:10.1016/j.gene.2025.149820.

    PMID: 41075949
  47. 47

    Additional diagnostic potential of transbronchial lung cryobiopsy in bronchoscopic assessment of sarcoidosis and chronic beryllium disease: a retrospective analysis of 321 patients.

    Terschluse C, Feineis M, Jouanjan L, et al.

    BMJ open respiratory research 2025; (12(1)) doi:10.1136/bmjresp-2025-003206.

    PMID: 41407395
  48. 48

    CT Imaging Features of Pulmonary Sarcoidosis: Typical and Atypical Radiological Features and Their Differential Diagnosis.

    Baratella E, di Luca V, Oliva A, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(12)) doi:10.3390/medicina61122094.

    PMID: 41470097
  49. 49

    New aspects of chronic beryllium disease.

    Morgan A, MacMurdo MG

    Current opinion in allergy and clinical immunology 2026; (26(2)):100-106 doi:10.1097/ACI.0000000000001140.

    PMID: 41538467
  50. 50

    Beryllium Sulfate-Induced Cellular Senescence via the IL-6/STAT3 Pathway to Promote Pulmonary Fibrosis.

    Lu Y, Li Y, Tong Y, et al.

    Journal of applied toxicology : JAT 2026; (46(10)):3530-3541 doi:10.1002/jat.70199.

    PMID: 41974632